615731650	615731650	CD	B-NP	O
|	|	NN	I-NP	O
YMC	YMC	NN	I-NP	O
|	|	NN	I-NP	O
09399642	09399642	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
738903	738903	CD	B-NP	O
|	|	CC	I-NP	O
6/3/1998	6/3/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
GRAM	GRAM	NN	I-NP	I-protein
NEGATIVE	NEGATIVE	NN	I-NP	I-protein
ROD	ROD	NN	I-NP	I-protein
SEPSIS	SEPSIS	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/19/1998	5/19/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/25/1998	1/25/1998	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
GRAM	GRAM	NN	B-NP	O
NEGATIVE	NEGATIVE	NN	I-NP	O
ROD	ROD	NN	I-NP	O
BACTEREMIA	BACTEREMIA	NN	I-NP	O
.	.	.	O	O

PROBLEMS	PROBLEMS	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

APLASTIC	APLASTIC	NN	B-NP	O
ANEMIA	ANEMIA	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HEMOCHROMATOSIS	HEMOCHROMATOSIS	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT/IDENTIFICATION	COMPLAINT/IDENTIFICATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
34	34	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
22	22	CD	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
transfusion	transfusion	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
for	for	IN	B-PP	O
13	13	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
hemochromatosis	hemochromatosis	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
rod	rod	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
PRESENT	PRESENT	JJ	I-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
34	34	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
22	22	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
donor	donor	NN	I-NP	O
for	for	IN	B-PP	O
transplant	transplant	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
immunosuppressive	immunosuppressive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
aplastic	aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
using	use	VBG	B-VP	O
steroids	steroid	NNS	B-NP	O
without	without	IN	B-PP	O
efficacy	efficacy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
suffered	suffer	VBD	B-VP	O
complications	complication	NNS	B-NP	O
from	from	IN	B-PP	O
steroid	steroid	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
avascular	avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
hip	hip	NN	I-NP	O
replacements	replacement	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chronic	chronic	JJ	B-NP	O
bony	bony	JJ	I-NP	O
damage	damage	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
shoulders	shoulder	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
uses	use	VBZ	B-VP	O
pain	pain	NN	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
13	13	CD	I-NP	O
year	year	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
transfusion	transfusion	NN	B-NP	O
dependent	dependent	JJ	I-NP	O
and	and	CC	O	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
units	unit	NNS	I-NP	O
on	on	IN	B-PP	O
packed	pack	VBN	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
an	an	DT	B-NP	O
every	every	DT	I-NP	O
two	two	CD	I-NP	O
week	week	NN	I-NP	O
basis	basis	NN	I-NP	O
and	and	CC	I-NP	O
platelet	platelet	NN	I-NP	O
transfusions	transfusion	NNS	I-NP	O
whenever	whenever	WRB	B-ADVP	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
epistaxis	epistaxis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
already	already	RB	I-VP	O
been	be	VBN	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
ferratin	ferratin	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
blood	blood	NN	B-NP	O
transfusions	transfusion	NNS	I-NP	O
from	from	IN	B-PP	O
years	year	NNS	B-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Desferal	Desferal	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
port-a-cath	port-a-cath	JJ	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-ADVP	O
leakage	leakage	NN	B-NP	O
of	of	IN	B-PP	O
Desferal	Desferal	NNP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
extrusion	extrusion	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
port-a-cath	port-a-cath	NN	I-NP	O
through	through	IN	B-PP	O
her	her	PRP$	B-NP	O
skin	skin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	B-ADVP	O
off	off	RP	B-PRT	O
Desferal	Desferal	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
years	year	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
September	September	NNP	I-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
500	500	CD	I-NP	O
to	to	TO	I-NP	O
600	600	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
polyuria	polyuria	NN	B-NP	O
,	,	,	O	O
polydipsia	polydipsia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
19	19	CD	I-NP	O
pound	pound	NN	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
iron	iron	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ferratin	ferratin	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
7	7	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
Desferal	Desferal	JJ	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
port-a-cath	port-a-cath	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Desferal	Desferal	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
per	per	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
gradual	gradual	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
Insulin	Insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
by	by	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
on	on	IN	B-PP	O
vacation	vacation	NN	B-NP	O
to	to	TO	B-PP	O
Wark	Wark	NNP	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Toward	Toward	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
infected	infected	JJ	I-NP	O
port-a-cath	port-a-cath	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Jera	Jera	NNP	I-NP	O
Counta	Counta	NNP	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
April	April	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
port-a-cath	port-a-cath	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
four	four	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
long	long	JJ	I-NP	O
term	term	NN	I-NP	O
sequelae	sequela	NNS	I-NP	O
of	of	IN	B-PP	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Nafcillin	Nafcillin	NN	B-NP	B-protein
for	for	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
Nafcillin	Nafcillin	NN	B-NP	B-protein
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Biehay	Biehay	NNP	I-NP	O
Sciencesmot	Sciencesmot	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
to	to	TO	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
day	day	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
fevers	fever	NNS	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
painful	painful	JJ	I-NP	O
perirectal	perirectal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abscess	abscess	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
and	and	CC	O	O
required	require	VBN	B-VP	O
surgical	surgical	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
to	to	TO	B-PP	O
42	42	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
incision	incision	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
Imount	Imount	NNP	I-NP	O
Sheo	Sheo	NNP	I-NP	O
Bona	Bona	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
abscess	abscess	NN	I-NP	O
grew	grow	VBD	B-VP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
enteric	enteric	JJ	I-NP	O
rods	rod	NNS	I-NP	O
,	,	,	O	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
Cipro	Cipro	NNP	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Speciation	Speciation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gram	gram	NN	I-NP	O
negative	negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
Klebsiella	Klebsiella	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
took	take	VBD	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
ten	ten	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
off	off	RP	B-PRT	O
all	all	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-SBAR	O
Licausi	Licausi	NNP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
another	another	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
to	to	TO	B-VP	O
document	document	VB	I-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
infection	infection	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
putting	put	VBG	B-VP	O
in	in	RP	B-PRT	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
central	central	JJ	I-NP	O
access	access	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
a	a	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
H	H	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Health	Health	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
entirely	entirely	RB	B-ADJP	O
afebrile	afebrile	JJ	I-ADJP	O
without	without	IN	B-PP	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Insulin	Insulin	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Do	Do	NNP	I-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
rod	rod	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Aplastic	Aplastic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hemochromatosis	Hemochromatosis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Avascular	Avascular	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
and	and	CC	O	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
grade	grade	NN	I-NP	O
SIL	SIL	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
transfusions	transfusion	NNS	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
port-a-cath	port-a-cath	JJ	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
65	65	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.	q.	VBP	B-VP	O
a.m.	a.m.	NN	B-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
and	and	CC	O	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
q.	q.	VBP	B-VP	O
a.m.	a.m.	NN	B-NP	O
of	of	IN	B-PP	O
Regular	Regular	NNP	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Regular	Regular	JJ	B-NP	O
subcutaneously	subcutaneously	RB	B-ADJP	O
pre-dinner	pre-dinner	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Desferal	Desferal	JJ	B-NP	O
2	2	CD	I-NP	O
gram	gram	NN	I-NP	O
intravenously	intravenously	RB	B-NP	O
q.	q.	RB	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
five	five	CD	I-NP	O
year	year	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
mother	mother	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
ages	age	NNS	B-NP	O
12	12	CD	I-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
extended	extend	VBN	I-NP	O
family	family	NN	I-NP	O
members	member	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
young	young	JJ	I-NP	O
African-American	African-American	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Clear	Clear	JJ	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
previous	previous	JJ	I-NP	O
port-a-cath	port-a-cath	JJ	I-NP	O
size	size	NN	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
healed	heal	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
induration	induration	NN	I-NP	O
or	or	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
PICC	PICC	NN	I-NP	O
line	line	NN	I-NP	O
site	site	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

BACK	BACK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Recent	Recent	JJ	B-NP	O
perirectal	perirectal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
shows	show	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
good	good	JJ	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
induration	induration	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
warmth	warmth	NN	I-NP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
99.8	99.8	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
116/80	116/80	CD	B-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
76	76	CD	B-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

Oxygen	Oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Drawn	Drawn	NN	B-NP	O
at	at	IN	B-PP	O
Ow	Ow	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
And	And	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
on	on	IN	B-PP	O
2/8/98	2/8/98	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
differential	differential	JJ	I-NP	O
showing	show	VBG	I-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
23	23	CD	B-NP	O
,	,	,	O	O
bands	band	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
,	,	,	O	O
atypicals	atypical	NNS	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ANC	ANC	NNP	I-NP	O
483	483	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
11	11	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
266	266	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.2	2.2	CD	I-NP	O
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	I-NP	O
029	029	CD	I-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	B-DNA
145	145	CD	I-NP	I-DNA
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
227	227	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.0	1.0	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Oncology	Oncology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
1	1	CD	B-NP	O
gram	gram	NN	I-NP	O
of	of	IN	B-PP	O
Ceftazidine	Ceftazidine	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Ge	Ge	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
rod	rod	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
while	while	IN	B-SBAR	O
awaiting	await	VBG	B-VP	O
speciation	speciation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

INFECTIOUS	INFECTIOUS	JJ	B-NP	O
DISEASE	DISEASE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	ch	JJS	I-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/98	2/8/98	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
four	four	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
bottles	bottle	NNS	I-NP	O
growing	grow	VBG	B-VP	O
Bacillus	Bacillus	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/11/98	5/11/98	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
Bacillus	Bacillus	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
growing	grow	VBG	I-NP	O
Bacillus	Bacillus	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unrevealing	unreveale	VBG	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
comment	comment	NN	I-NP	O
made	make	VBN	B-VP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
liver	liver	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
estuta	estuta	NN	B-NP	O
flow	flow	NN	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
consultation	consultation	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
afebrile	afebrile	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
.	.	.	O	O

Recommendations	Recommendation	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
Infection	Infection	NN	B-NP	O
Disease	Disease	NN	I-NP	O
to	to	TO	B-VP	O
discontinue	discontinue	VB	I-VP	O
Levofloxacin	Levofloxacin	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
2/15/98	2/15/98	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
on	on	IN	B-PP	O
1/3/98	1/3/98	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
blood	blood	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right	right	JJ	I-NP	O
PICC	PICC	NN	I-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HEMATOLOGY	HEMATOLOGY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
18	18	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
24	24	CD	B-NP	O
on	on	IN	B-PP	O
5/11/98	5/11/98	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
4	4	CD	B-NP	O
on	on	IN	B-PP	O
5/11/98	5/11/98	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
bag	bag	NN	I-NP	O
of	of	IN	B-PP	O
platelets	platelet	NNS	B-NP	B-cell_type
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
to	to	TO	B-PP	O
43	43	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Desferal	Desferal	NNP	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
q.	q.	NN	I-NP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
Insulin	Insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
65	65	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
q.	q.	NN	I-NP	I-protein
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Regular	Regular	JJ	B-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	RB	B-ADVP	O
,	,	,	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Regular	Regular	JJ	B-NP	O
pre-dinner	pre-dinner	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Desferol	Desferol	NN	B-NP	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
intravenously	intravenously	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Percocet	Percocet	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
q.	q.	VBP	B-VP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Randell	Randell	NNP	I-NP	O
M	M	NNP	I-NP	O
Cadriel	Cadriel	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Skrip	Skrip	NNP	I-NP	O
for	for	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
if	if	IN	B-SBAR	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
Attending	Attend	VBG	B-VP	O
:	:	:	O	O
KORY	KORY	NNP	B-NP	O
F.	F.	NNP	I-NP	O
TATA	TATA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HM87	HM87	NNP	I-NP	O
AH054/5112	AH054/5112	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
24690	24690	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QOXIKX2M6G	QOXIKX2M6G	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/3/98	3/3/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/4/98	10/4/98	CD	B-NP	O

